Navigation Links
New Report Illuminates Ampligen's Unique Mechanism of Action

of dsRNAs for the induction of innate immunity. Unlike the toxic Poly I:Poly C, Ampligen is directed towards the activation of TLR-3 in the induction of innate immune responses.

The closely allied compound, Poly I : Poly C, has been used in clinical trials but has a broad range of side-effects, some of which are life-threatening. Where the studies found specific involvement of TLR-3 in conveying Ampligen(R)'s biologic properties, no such specificity was seen with poly I : poly C, thus explaining its side effect profile without compromising its potency as an immunotherapeutic.

The findings further establish the remarkable specificity of Ampligen(R) in activating the critical first line of defense against various types of pathogenic elements. The findings are pertinent to many cutting edge therapeutic topics in biotechnology today, including the enhancement of vaccine efficacy (both antiviral and anticancer) as well as strengthening biologic therapy (interferons, interleukins, etc.) of various serious human diseases as well as enhancing traditional antivirals such as Tamiflu(R) and Relenza(R).

The experimental therapeutic Ampligen(R) is perhaps the best studied TLR activator in human clinical trials to date, having been administered more than 75,000 times in approximately 15 clinical trials of which four were very well-controlled (placebo-controlled, randomized, multi-center, double-blinded).

"These scientific findings go a long way toward explaining how a single, relatively simple compound, Ampligen(R), can repeatedly show therapeutic promise in such a broad array of indications. The findings may also have broad economic implications for the American biotechnology sector," commented Dr. William A. Carter, Chairman and CEO of Hemispherx Biopharama, Inc. "According to a recent KPMG Bioscience report, our sector recently achieved a new high of $70 billion in revenues a year, but is now faced with many very short product life cycles, large po
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Report Illuminates Ampligen Unique Mechanism Action
(Date:3/3/2015)...  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) ... engaged in the design, development and production of ... medical device companies has announced the acquisition of ... medical cable manufacturer based in North Carolina.  The ... the name MTI Medical Cables.  ...
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
(Date:3/3/2015)... Registration is officially open for MEDTEC China South ... the Shenzhen Convention & Exhibition Center. The Shenzhen ... join the MEDTEC China family of events. MEDTEC China South, ... better serve the South China market ... important region for China,s medical device ...
Breaking Medicine Technology:American Biosurgical Acquires MTI Corporation 2Web Industries Receives 3M Preferred Converter Status 2Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3
... , VIENNA, Va., Dec. 1 CEL-SCI Corporation (NYSE Amex: ... of vaccines and therapeutics for the prevention and treatment of ... of an international Contract Research Organization (CRO) to run CEL-SCI,s ... neck cancer with the Company,s lead product candidate, Multikine®. ...
... , MT. LAUREL, N.J., Dec. 1 MedQuist ... clinical documentation services, today announced that the radiology search tool ... Radiology(TM), MedQuist,s real-time speech recognition system. The solution is being ... November 29 through December 2. , Radiologists ...
Cached Medicine Technology:CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2
(Date:3/4/2015)... 2015 Follow us on ... growth worldwide, supported by the numerous intraoperative, and ... and single incision surgery will continue to spur ... invasive surgery, driving its adoption among patients and ... site, lower blood loss, shorter hospital stays, faster ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Bird B ... industrial and residential applications now offers its popular plastic ... The humane, highly efficient bird deterrent is ... match the color and décor of the building or ... colors—brick red, white, crystal clear, light grey, brown, black ...
(Date:3/4/2015)... Mexia, Texas & Ennis, Texas (PRWEB) March 04, ... Ennis Regional Medical Center today announced that Alan ... of both hospitals, effective immediately. Daugherty has served ... Regional since October 2014. , “Alan has provided ... and has demonstrated exceptional abilities leading hospital strategy ...
(Date:3/3/2015)... Anik Singal's Profit Academy ... ambitious online marketers has become the talk of ... media attention surrounding the course's general release has ... Hendricks, prompting her to review the program's content ... of the biggest keys to success with Internet ...
(Date:3/3/2015)... Loma Linda University Health announced today, ... being, it will be offering new, healthier choices in ... Over the past year, a cross-section of Loma Linda ... criteria, listening to vendors, sampling their products, and ultimately ... , Most recently, a food fair was held during ...
Breaking Medicine News(10 mins):Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2
... from the University of Washington, Seattle, and colleagues, have ... Moderately elevated levels of insulin increase the levels ... in cerebrospinal fluid and these markers may contribute to ... healthy older adults ranging in age from 55 to ...
... Hyderabad has unraveled the mystery behind gene silencing, paving ... in human beings//. ,Two scientists - Manika Pal ... novel finding to fight a disease, which has remained ... silencing segments of the genes (heterochromatin), which are responsible ...
... is a complex decision and early detection of cancer will ... problems for others leading to unnecessary testing and treatment. Celebrities ... can be used for early detection of cancer// , ... in the Journal of the National Cancer Institute reported that ...
... University School of Medicine had said in a research finding ... that the disease called Rocky Mountain spotted fever may spread ... ,The research highlights the importance of the recent outbreak ... be traced back to ticks carried into to the state ...
... has been designed to help researchers track a tracer chemical, monamine ... enzyme has been found to play a crucial role in blood ... B. ,The study showed that levels of MAO B ... - were reduced by 40 to 50 percent compared to non-smokers. ...
... elderly people who exercise regularly and have a certain gene ... movements than the people who lack the gene expression. ... School of Medicine was published // in the latest issue ... climbing steps) is common and is strongly related to major ...
Cached Medicine News:Health News:Influence of Celebrities on Breast Cancer Awareness 2Health News:Influence of Celebrities on Breast Cancer Awareness 3Health News:Influence of Celebrities on Breast Cancer Awareness 4Health News:Influence of Celebrities on Breast Cancer Awareness 5Health News:Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts 2Health News:Gene Variation Associated With Better Mobility For Older Individuals 2
... Only 1-2% of circulating testosterone exists as ... 60%, is bound to SHBG with high ... bound to albumin. Both the albumin-bound and ... SHBG effectively inhibits testosterone action. Measurement of ...
... (T4) is the primary active hormone synthesized ... gland [1]. T4 is synthesized via a ... by the follicular cells, (ii) iodination of ... to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT ...
... Human Insulin-like growth factor binding protein-3 (IGFBP-3) is ... in postnatal serum, as a component of the ... IGFBP-3, a molecule of IGF-I or IGF-II and ... the actions of the IGFs. The molar concentration ...
... (GH) is a monomeric protein produced and ... gland. GH is released from the pituitary ... under the regulatory control of hypothalamic somatostatin ... timing and frequency of GH release appears ...
Medicine Products: